Legend Biotech (LEGN) Assets Average (2020 - 2021)
Legend Biotech (LEGN) has disclosed Assets Average for 2 consecutive years, with $920.8 million as the latest value for Q4 2021.
- For the quarter ending Q4 2021, Assets Average rose 82.37% year-over-year to $920.8 million, compared with a TTM value of $920.8 million through Dec 2021, up 82.37%, and an annual FY2021 reading of $920.8 million, up 82.37% over the prior year.
- Assets Average was $920.8 million for Q4 2021 at Legend Biotech, up from $504.9 million in the prior quarter.
- Across five years, Assets Average topped out at $920.8 million in Q4 2021 and bottomed at $504.9 million in Q4 2020.